<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Investigating the Antioxidant Effects of Hesperidin on Liver Tissue in Mice with Acute Malathion Toxicity</ArticleTitle>
<VernacularTitle>Investigating the Antioxidant Effects of Hesperidin on Liver Tissue in Mice with Acute Malathion Toxicity</VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>11</LastPage>
			<ELocationID EIdType="pii">245522</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2026.554165.4048</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Mohammad Amin</FirstName>
					<LastName>Abdolahi Ziaaldini</LastName>
<Affiliation>Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
<Identifier Source="ORCID">0009-0001-4709-007X</Identifier>

</Author>
<Author>
					<FirstName>Nadia</FirstName>
					<LastName>Yousefi</LastName>
<Affiliation>Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Zabihullah</FirstName>
					<LastName>Mohaqiq</LastName>
<Affiliation>Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran..</Affiliation>
<Identifier Source="ORCID">0000-0002-9614-5866</Identifier>

</Author>
<Author>
					<FirstName>Hamed</FirstName>
					<LastName>Shoorei</LastName>
<Affiliation>Assistant Professor of Anatomical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-7762-5362</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>10</Month>
					<Day>21</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background and Objectives&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;Malathion is an organophosphate compound that can cause severe damage to organs such as the liver. It exerts its toxic effects through inhibition of cholinesterase and induction of oxidative stress. Hesperidin, a flavonoid with antioxidant and anti-inflammatory properties, may have a protective role against this damage. The aim of this study was to investigate the protective effect of hesperidin against acute malathion-induced liver injury in female Syrian mice. &lt;br&gt;&lt;strong&gt;Subjects and Methods&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;In this experimental study, 32 female Syrian mice were randomly divided into four groups: negative control, malathion, hesperidin, and treatment (malathion + hesperidin). Malathion (3 mg/kg) and hesperidin (20 mg/kg) were administered intraperitoneally for 35 consecutive days. At the end of the treatment period, following anesthesia, cardiac blood sampling and liver tissue collection were performed. Data were analyzed using SPSS version 24, with statistical significance set at (p&lt;0.05).&lt;br&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;In the malathion group, histopathological alterations in liver tissue were observed, and serum levels of ALT, AST, ALP, and both total and direct bilirubin were significantly increased (P&lt;0.05). In the treatment group, these markers were significantly reduced, and histological improvement of liver tissue was evident (P&lt;0.05). Total antioxidant capacity (TAC) decreased in the malathion group while it increased in the hesperidin and treatment groups (P&lt;0.05). Additionally, malondialdehyde (MDA) levels were significantly elevated in the malathion group but significantly reduced in the malathion+hesperidin group (P&lt;0.05). &lt;br&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;Malathion induced histopathological changes and enzymatic disturbances in the liver, whereas hesperidin effectively mitigated these effects. Therefore, hesperidin may serve as a protective agent against malathion-induced hepatotoxicity.</Abstract>
			<OtherAbstract Language="FA">&lt;strong&gt;Background and Objectives&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;Malathion is an organophosphate compound that can cause severe damage to organs such as the liver. It exerts its toxic effects through inhibition of cholinesterase and induction of oxidative stress. Hesperidin, a flavonoid with antioxidant and anti-inflammatory properties, may have a protective role against this damage. The aim of this study was to investigate the protective effect of hesperidin against acute malathion-induced liver injury in female Syrian mice. &lt;br&gt;&lt;strong&gt;Subjects and Methods&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;In this experimental study, 32 female Syrian mice were randomly divided into four groups: negative control, malathion, hesperidin, and treatment (malathion + hesperidin). Malathion (3 mg/kg) and hesperidin (20 mg/kg) were administered intraperitoneally for 35 consecutive days. At the end of the treatment period, following anesthesia, cardiac blood sampling and liver tissue collection were performed. Data were analyzed using SPSS version 24, with statistical significance set at (p&lt;0.05).&lt;br&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;In the malathion group, histopathological alterations in liver tissue were observed, and serum levels of ALT, AST, ALP, and both total and direct bilirubin were significantly increased (P&lt;0.05). In the treatment group, these markers were significantly reduced, and histological improvement of liver tissue was evident (P&lt;0.05). Total antioxidant capacity (TAC) decreased in the malathion group while it increased in the hesperidin and treatment groups (P&lt;0.05). Additionally, malondialdehyde (MDA) levels were significantly elevated in the malathion group but significantly reduced in the malathion+hesperidin group (P&lt;0.05). &lt;br&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;Malathion induced histopathological changes and enzymatic disturbances in the liver, whereas hesperidin effectively mitigated these effects. Therefore, hesperidin may serve as a protective agent against malathion-induced hepatotoxicity.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Malathion</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">hesperidin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hepatic injury</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">oxidative stress</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_245522_124e95ba5fbc12b2fb1392841e71eb47.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Investigating the Relationship between Depression and Eating Behavior in Students of Ahvaz Jundishapur University of Medical Sciences and Shahid Chamran University of Ahvaz</ArticleTitle>
<VernacularTitle>Investigating the Relationship between Depression and Eating Behavior in Students of Ahvaz Jundishapur University of Medical Sciences and Shahid Chamran University of Ahvaz</VernacularTitle>
			<FirstPage>12</FirstPage>
			<LastPage>20</LastPage>
			<ELocationID EIdType="pii">245521</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2026.558887.4078</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Seyedeh Taravat</FirstName>
					<LastName>Mortazavi</LastName>
<Affiliation>Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>
<Identifier Source="ORCID">0009-0002-9576-9236</Identifier>

</Author>
<Author>
					<FirstName>Seyedeh Yekta</FirstName>
					<LastName>Mortazavi</LastName>
<Affiliation>Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad Parsa</FirstName>
					<LastName>Bayat</LastName>
<Affiliation>Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Rahim Nezhad</LastName>
<Affiliation>Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Sima</FirstName>
					<LastName>Jafarirad</LastName>
<Affiliation>Nutrition and Metabolic Diseases Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-3161-5329</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>10</Day>
				</PubDate>
			</History>
		<Abstract>Abstract &lt;br&gt;&lt;br&gt;Background and Objective: Eating behavior is one of the factors that affects the quality and quantity of food intake and consequently influences human health. This behavior may be influenced by depression, a common mental health disorder that significantly affects individuals’ emotional and psychological well-being. Given the notable prevalence of depression among students, this study sought to examine the association between depression and eating behavior in students at Jundishapur University of Ahvaz and Shahid Chamran University.&lt;br&gt;Materials and Methods: A total of 225 participants completed the Personal Information Questionnaire, the Eating Behavior Questionnaire (which assesses eating behavior and classifies it into emotional, external, and restrained eating), and the Beck Depression Inventory-II. &lt;br&gt;Findings: The results showed no significant difference in eating behavior between students at the two universities, while the difference in depression levels approached statistical significance (p = 0.05). A significant positive association was found between depression and external eating behavior (p = 0.005), while the association with emotional eating behavior was marginally significant (p = 0.056). No significant relationship was observed between depression and restrained eating behavior.&lt;br&gt;Conclusion: This study examined the relationship between depression and eating behavior. It appears that controlling and treating depression can improve eating behaviors and, consequently, overall health. &lt;br&gt;&lt;br&gt;Keywords: Eating behavior patterns, Depression, Student </Abstract>
			<OtherAbstract Language="FA">Abstract &lt;br&gt;&lt;br&gt;Background and Objective: Eating behavior is one of the factors that affects the quality and quantity of food intake and consequently influences human health. This behavior may be influenced by depression, a common mental health disorder that significantly affects individuals’ emotional and psychological well-being. Given the notable prevalence of depression among students, this study sought to examine the association between depression and eating behavior in students at Jundishapur University of Ahvaz and Shahid Chamran University.&lt;br&gt;Materials and Methods: A total of 225 participants completed the Personal Information Questionnaire, the Eating Behavior Questionnaire (which assesses eating behavior and classifies it into emotional, external, and restrained eating), and the Beck Depression Inventory-II. &lt;br&gt;Findings: The results showed no significant difference in eating behavior between students at the two universities, while the difference in depression levels approached statistical significance (p = 0.05). A significant positive association was found between depression and external eating behavior (p = 0.005), while the association with emotional eating behavior was marginally significant (p = 0.056). No significant relationship was observed between depression and restrained eating behavior.&lt;br&gt;Conclusion: This study examined the relationship between depression and eating behavior. It appears that controlling and treating depression can improve eating behaviors and, consequently, overall health. &lt;br&gt;&lt;br&gt;Keywords: Eating behavior patterns, Depression, Student </OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Keywords: Eating behavior patterns</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">depression</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Student</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_245521_dc6aadf19db6b9ce4d6355c2f094e954.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Effect of High-Dose Ascorbic Acid on Necroptosis Pathway Activation in the HT29 Colon Cancer Cell Line</ArticleTitle>
<VernacularTitle>The Effect of High-Dose Ascorbic Acid on Necroptosis Pathway Activation in the HT29 Colon Cancer Cell Line</VernacularTitle>
			<FirstPage>21</FirstPage>
			<LastPage>29</LastPage>
			<ELocationID EIdType="pii">243314</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2025.519570.3883</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Samaneh</FirstName>
					<LastName>Karimi</LastName>
<Affiliation>Department of Anatomical Sciences, Faculty of Medicine,  University of Medical Sciences, َAbadan, Abadan,, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Negar</FirstName>
					<LastName>Shafi</LastName>
<Affiliation>Student Research Committee, Abadan University of Medical Sciences, Abadan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Arghavan</FirstName>
					<LastName>Afra</LastName>
<Affiliation>Abadan University of Medical Science, Abadan, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0001-8794-1636</Identifier>

</Author>
<Author>
					<FirstName>, Fereshtesadat</FirstName>
					<LastName>Fakhredini</LastName>
<Affiliation>Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Kogani</LastName>
<Affiliation>Research Center for Environmental Contaminants (RCEC), Abadan University of Medical Sciences, Abadan, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-4283-3441</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>04</Month>
					<Day>27</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Hydatidiform mole (HM) is a rare gestational trophoblastic disease characterized by abnormal growth of trophoblastic tissue. The aim of this study was to determine the prevalence and identify the risk factors associated with hydatidiform mole among patients referred to Shahid Beheshti Educational Hospital in Abadan from 2018 to 2022. &lt;br&gt;Methods: This descriptive-analytical study was conducted on 67 patients diagnosed with hydatidiform mole who referred to Shahid Beheshti Educational Hospital in Abadan during 2018–2022. Data were collected by reviewing medical records using a checklist that included demographic characteristics, obstetric history, and clinical status. Data analysis was performed using SPSS version 22 and Chi-square and Fisher’s exact tests. &lt;br&gt;Results: Of the 67 patients, 6 (9%) had complete mole and 61 (91%) had partial mole. No significant difference was observed in the frequency of mole types according to age, ethnicity, occupation, and education level. However, a significant association was found between the spouse’s occupation and mole type; the prevalence of complete mole was higher among patients whose spouses were government employees (P=0.032). In addition, uterine size larger than gestational age and history of vaginal bleeding were associated with a higher frequency of complete mole (P=0.029). &lt;br&gt;Conclusion: The results of this study suggest that spouse’s occupation, uterine size larger than gestational age, and history of vaginal bleeding may be important risk factors for hydatidiform mole. These findings may contribute to a better understanding of the pathogenesis of the disease and could potentially pave the way for developing preventive strategies and early interventions.</Abstract>
			<OtherAbstract Language="FA">Introduction: Hydatidiform mole (HM) is a rare gestational trophoblastic disease characterized by abnormal growth of trophoblastic tissue. The aim of this study was to determine the prevalence and identify the risk factors associated with hydatidiform mole among patients referred to Shahid Beheshti Educational Hospital in Abadan from 2018 to 2022. &lt;br&gt;Methods: This descriptive-analytical study was conducted on 67 patients diagnosed with hydatidiform mole who referred to Shahid Beheshti Educational Hospital in Abadan during 2018–2022. Data were collected by reviewing medical records using a checklist that included demographic characteristics, obstetric history, and clinical status. Data analysis was performed using SPSS version 22 and Chi-square and Fisher’s exact tests. &lt;br&gt;Results: Of the 67 patients, 6 (9%) had complete mole and 61 (91%) had partial mole. No significant difference was observed in the frequency of mole types according to age, ethnicity, occupation, and education level. However, a significant association was found between the spouse’s occupation and mole type; the prevalence of complete mole was higher among patients whose spouses were government employees (P=0.032). In addition, uterine size larger than gestational age and history of vaginal bleeding were associated with a higher frequency of complete mole (P=0.029). &lt;br&gt;Conclusion: The results of this study suggest that spouse’s occupation, uterine size larger than gestational age, and history of vaginal bleeding may be important risk factors for hydatidiform mole. These findings may contribute to a better understanding of the pathogenesis of the disease and could potentially pave the way for developing preventive strategies and early interventions.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">hydatidiform mole</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Gestational trophoblastic disease</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">risk factors</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Epidemiology</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_243314_3d990cd11ee0cd6f94c311955e2a49c9.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Effect of High-Dose Ascorbic Acid on Necroptosis Pathway Activation in the HT29 Colon Cancer Cell Line</ArticleTitle>
<VernacularTitle>The Effect of High-Dose Ascorbic Acid on Necroptosis Pathway Activation in the HT29 Colon Cancer Cell Line</VernacularTitle>
			<FirstPage>30</FirstPage>
			<LastPage>41</LastPage>
			<ELocationID EIdType="pii">242771</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2026.544167.3978</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Dian</FirstName>
					<LastName>Dayer</LastName>
<Affiliation>Cellular and Molecular Research Center,, Medical Basic Sciences Institute, Ahvaz Jundishapur University of Medical Sciences.</Affiliation>
<Identifier Source="ORCID">0000-0001-5893-6379</Identifier>

</Author>
<Author>
					<FirstName>Zahra</FirstName>
					<LastName>Shokati Eshkiki</LastName>
<Affiliation>Alimentary Tract Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Kosar</FirstName>
					<LastName>Abbasi Samie</LastName>
<Affiliation>Alimentary Tract Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>08</Month>
					<Day>31</Day>
				</PubDate>
			</History>
		<Abstract>Objective: The effect of high dosages of ascorbic acid on the expression of major necroptosis pathway genes in HT-29 colon cancer cells was studied. Materials and methods: HT-29 cells were cultured in DMEM-HG medium containing 10% FBS and 1% Pen/Strep and incubated at 37°C with 5% CO2. After reaching 90% density, the cells were trypsinised and cultured in triplicate in 12-well culture plates at 30,000 cells per well. The cells were divided into two groups: a control group that received only basal culture medium and a test group that received 5 mM ascorbic acid for 3 hours. After 24 hours, the cell supernatant and the cell pellet were collected for further analysis. LDH activity was assessed using the kinetic technique, and the proportion of apoptosis and necrosis was calculated using flow cytometry. Gene expression analysis was performed using real-time PCR. Statistical analysis was performed using GraphPad Prism software version 8 and a t-test. Results: Microscopic images and flow cytometry results confirmed the induction of necroptosis by ascorbic acid. In addition, ascorbic acid treatment significantly increased key necroptosis gene expression and LDH activity. Conclusion: High dosages of ascorbic acid activate necroptosis in HT-29 cells.</Abstract>
			<OtherAbstract Language="FA">Objective: The effect of high dosages of ascorbic acid on the expression of major necroptosis pathway genes in HT-29 colon cancer cells was studied. Materials and methods: HT-29 cells were cultured in DMEM-HG medium containing 10% FBS and 1% Pen/Strep and incubated at 37°C with 5% CO2. After reaching 90% density, the cells were trypsinised and cultured in triplicate in 12-well culture plates at 30,000 cells per well. The cells were divided into two groups: a control group that received only basal culture medium and a test group that received 5 mM ascorbic acid for 3 hours. After 24 hours, the cell supernatant and the cell pellet were collected for further analysis. LDH activity was assessed using the kinetic technique, and the proportion of apoptosis and necrosis was calculated using flow cytometry. Gene expression analysis was performed using real-time PCR. Statistical analysis was performed using GraphPad Prism software version 8 and a t-test. Results: Microscopic images and flow cytometry results confirmed the induction of necroptosis by ascorbic acid. In addition, ascorbic acid treatment significantly increased key necroptosis gene expression and LDH activity. Conclusion: High dosages of ascorbic acid activate necroptosis in HT-29 cells.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Ascorbic acid</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Necroptosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Colon cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">HT29 Cell line</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_242771_d0f4fab7bae7aef08d1578066de233ca.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Effect of High-Intensity Exercise Training on Serum Levels of Beta-Aminoisobutyric Acid and Insulin Resistance in Men with Non-Alcoholic Fatty Liver Disease</ArticleTitle>
<VernacularTitle>The Effect of High-Intensity Exercise Training on Serum Levels of Beta-Aminoisobutyric Acid and Insulin Resistance in Men with Non-Alcoholic Fatty Liver Disease</VernacularTitle>
			<FirstPage>42</FirstPage>
			<LastPage>52</LastPage>
			<ELocationID EIdType="pii">245527</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2026.571248.4132</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Marina</FirstName>
					<LastName>Shariati</LastName>
<Affiliation>Department of Physical Education &amp; Sport Sciences, Ahv.C., Islamic Azad University, Ahvaz, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-1937-331X</Identifier>

</Author>
<Author>
					<FirstName>Akbar</FirstName>
					<LastName>Ghalavand</LastName>
<Affiliation>Pediatric Gastroenterology and Hepatology Research Center, Zabol University of Medical Sciences, Zabol, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-1109-7867</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2026</Year>
					<Month>01</Month>
					<Day>07</Day>
				</PubDate>
			</History>
		<Abstract>Background and Objective: Non-alcoholic fatty liver disease (NAFLD) is a common obesity-related metabolic disorder associated with changes in metabolic proteins such as beta-aminoisobutyric acid (BAIBA). This study aimed to investigate the effects of high-intensity exercise on serum BAIBA levels and insulin resistance in men with NAFLD.&lt;br&gt;Methods: In this quasi-experimental study, 45 men with grade 1–2 NAFLD (BMI 30–35 kg/m², age 35–45 years) were randomly assigned to three groups: high-intensity interval training (HIIT), high-intensity CrossFit training (HICFT), and control. The interventions included 18 sessions over six weeks (three sessions/week) at 80–85% of heart rate reserve. Data were analyzed using paired t-tests, ANCOVA, and Bonferroni test (P ≤ 0.05).&lt;br&gt;Results: Significant increases in BAIBA levels and decreases in insulin resistance were observed in the HIIT (P &lt; 0.001) and HICFT groups (P = 0.007 for BAIBA; P &lt; 0.001 for insulin resistance) compared to the control group. No significant difference was found between the two exercise groups (P &gt; 0.05).&lt;br&gt;Conclusion: High-intensity exercises, whether HIIT or HICFT, can improve insulin resistance and regulate metabolic proteins such as BAIBA. These findings confirm the importance of exercise and myokines in managing NAFLD. High-intensity training is recommended as an effective non-pharmacological intervention for individuals with NAFLD.</Abstract>
			<OtherAbstract Language="FA">Background and Objective: Non-alcoholic fatty liver disease (NAFLD) is a common obesity-related metabolic disorder associated with changes in metabolic proteins such as beta-aminoisobutyric acid (BAIBA). This study aimed to investigate the effects of high-intensity exercise on serum BAIBA levels and insulin resistance in men with NAFLD.&lt;br&gt;Methods: In this quasi-experimental study, 45 men with grade 1–2 NAFLD (BMI 30–35 kg/m², age 35–45 years) were randomly assigned to three groups: high-intensity interval training (HIIT), high-intensity CrossFit training (HICFT), and control. The interventions included 18 sessions over six weeks (three sessions/week) at 80–85% of heart rate reserve. Data were analyzed using paired t-tests, ANCOVA, and Bonferroni test (P ≤ 0.05).&lt;br&gt;Results: Significant increases in BAIBA levels and decreases in insulin resistance were observed in the HIIT (P &lt; 0.001) and HICFT groups (P = 0.007 for BAIBA; P &lt; 0.001 for insulin resistance) compared to the control group. No significant difference was found between the two exercise groups (P &gt; 0.05).&lt;br&gt;Conclusion: High-intensity exercises, whether HIIT or HICFT, can improve insulin resistance and regulate metabolic proteins such as BAIBA. These findings confirm the importance of exercise and myokines in managing NAFLD. High-intensity training is recommended as an effective non-pharmacological intervention for individuals with NAFLD.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">non-alcoholic fatty liver disease</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Exercise training</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Beta-aminoisobutyric acid</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">insulin resistance</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_245527_3cc762f99eaf00aee99ac7cfd315f6c6.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of Physicochemical Properties of Activated Charcoal and Preparation, Analysis, and Comparison of Its Oral Capsule with a Commercial Sample</ArticleTitle>
<VernacularTitle>Evaluation of Physicochemical Properties of Activated Charcoal and Preparation, Analysis, and Comparison of Its Oral Capsule with a Commercial Sample</VernacularTitle>
			<FirstPage>53</FirstPage>
			<LastPage>65</LastPage>
			<ELocationID EIdType="pii">245524</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2025.511483.3857</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Hasti</FirstName>
					<LastName>Daryazadeh</LastName>
<Affiliation>Department of Medicinal Chemistry, Faculty  of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ali Asghar Hemmati</FirstName>
					<LastName>Hemmati</LastName>
<Affiliation>Department of Pharmacology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Neda</FirstName>
					<LastName>Bavarsad</LastName>
<Affiliation>Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Azar</FirstName>
					<LastName>Mostoufi</LastName>
<Affiliation>Department of Medicinal Chemistry, Faculty  of  Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Reza</FirstName>
					<LastName>Alavi</LastName>
<Affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mahsa</FirstName>
					<LastName>Toolabi</LastName>
<Affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-0551-4030</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>03</Month>
					<Day>09</Day>
				</PubDate>
			</History>
		<Abstract>Background and Aim: Activated charcoal, due to its porous structure and high adsorption capacity, is widely used in pharmaceutical formulations, including capsules, to reduce gastrointestinal absorption of toxins. Considering the limited domestic production and dependence on imported products, this study aimed to formulate and evaluate a locally produced activated charcoal capsule and compare it with a commercial sample.&lt;br&gt;&lt;br&gt;Methods: The physicochemical properties of the activated charcoal powder, including acid-soluble substances, chloride, sulfate, sulfide, cyanide compounds, and heavy metals, were assessed according to BP and USP pharmacopeial standards. In addition, Brunauer–Emmett–Teller (BET) analysis was performed to determine surface area and adsorption capacity. Capsules were prepared in powder and granule forms, followed by pre-formulation tests, including flowability and density, as well as pharmaceutical evaluations such as content uniformity and disintegration time.&lt;br&gt;&lt;br&gt;Results: The activated charcoal powder demonstrated acceptable physicochemical quality, and impurity levels were within pharmacopeial limits. The iodine number confirmed the high adsorption capacity of the sample. Powder-based capsules, with a surface area of 675 m²/g, showed greater adsorption capacity than granules (364 m²/g), while granulation improved flowability and density. The produced capsules were comparable to the commercial product in terms of content uniformity and disintegration time.&lt;br&gt;&lt;br&gt;Conclusion: The formulated activated charcoal capsules met pharmacopeial standards and exhibited appropriate performance. The higher adsorption capacity of the powder-based capsules suggests a potential therapeutic advantage. Overall, the findings indicate the feasibility of domestic production and its potential role in reducing reliance on imported activated charcoal products.</Abstract>
			<OtherAbstract Language="FA">Background and Aim: Activated charcoal, due to its porous structure and high adsorption capacity, is widely used in pharmaceutical formulations, including capsules, to reduce gastrointestinal absorption of toxins. Considering the limited domestic production and dependence on imported products, this study aimed to formulate and evaluate a locally produced activated charcoal capsule and compare it with a commercial sample.&lt;br&gt;&lt;br&gt;Methods: The physicochemical properties of the activated charcoal powder, including acid-soluble substances, chloride, sulfate, sulfide, cyanide compounds, and heavy metals, were assessed according to BP and USP pharmacopeial standards. In addition, Brunauer–Emmett–Teller (BET) analysis was performed to determine surface area and adsorption capacity. Capsules were prepared in powder and granule forms, followed by pre-formulation tests, including flowability and density, as well as pharmaceutical evaluations such as content uniformity and disintegration time.&lt;br&gt;&lt;br&gt;Results: The activated charcoal powder demonstrated acceptable physicochemical quality, and impurity levels were within pharmacopeial limits. The iodine number confirmed the high adsorption capacity of the sample. Powder-based capsules, with a surface area of 675 m²/g, showed greater adsorption capacity than granules (364 m²/g), while granulation improved flowability and density. The produced capsules were comparable to the commercial product in terms of content uniformity and disintegration time.&lt;br&gt;&lt;br&gt;Conclusion: The formulated activated charcoal capsules met pharmacopeial standards and exhibited appropriate performance. The higher adsorption capacity of the powder-based capsules suggests a potential therapeutic advantage. Overall, the findings indicate the feasibility of domestic production and its potential role in reducing reliance on imported activated charcoal products.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Activated charcoal</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">capsule</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Physicochemical properties</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Adsorption capacity</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_245524_7d9f00eac051d83b80f9c64b87b5c3fb.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Effect of Exercise Training and Nettle Supplementation on the Inflammatory-Anti-Inflammatory Balance in Women with Metabolic Syndrome</ArticleTitle>
<VernacularTitle>The Effect of Exercise Training and Nettle Supplementation on the Inflammatory-Anti-Inflammatory Balance in Women with Metabolic Syndrome</VernacularTitle>
			<FirstPage>66</FirstPage>
			<LastPage>76</LastPage>
			<ELocationID EIdType="pii">245528</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2025.564421.4099</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Somayeh</FirstName>
					<LastName>Behzadinezhad</LastName>
<Affiliation>Ph. D Student, Department of Exercise Physiology, Ki.C., Islamic Azad University, Kish, Iran.</Affiliation>
<Identifier Source="ORCID">0009-0009-1818-7743</Identifier>

</Author>
<Author>
					<FirstName>, Heshmatolah</FirstName>
					<LastName>Parsian</LastName>
<Affiliation>Associate Professor, Department of Physical Education and Sport Sciences, Shahr-e-Qods Branch, Islamic Azad .University, Iran</Affiliation>
<Identifier Source="ORCID">0009-0009-5088-4696</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Ali</FirstName>
					<LastName>Azarbayjani</LastName>
<Affiliation>Professor, Department of Physical Education and Sport Sciences, CT.C., Islamic Azad University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-3502-7487</Identifier>

</Author>
<Author>
					<FirstName>Rouhollah</FirstName>
					<LastName>Ershadi</LastName>
<Affiliation>Assistant Professor, Department of Physical Education and Sport Science, Bu.C., Islamic Azad University, Bushehr, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-3723-4014</Identifier>

</Author>
<Author>
					<FirstName>BI Fakhrosadat</FirstName>
					<LastName>Hashemi</LastName>
<Affiliation>Assistant Professor, Department of Physical Education and Sport Science, Bu.C., Islamic Azad University, Bushehr, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-0624-5717</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>12</Month>
					<Day>05</Day>
				</PubDate>
			</History>
		<Abstract>Background and Objective: Metabolic syndrome is associated with systemic inflammation and oxidative stress, which increase the risk of cardiovascular diseases. This study aimed to investigate the effects of eight weeks of concurrent exercise training and nettle supplementation the inflammatory-anti-inflammatory balance in women with metabolic syndrome.&lt;br&gt;Methods: In this semi-experimental study, 60 women with metabolic syndrome (aged 35–45 years) were randomly assigned to four groups of 15 participants each: 1) Exercise + Placebo, 2) Nettle Supplement, 3) Exercise + Nettle Supplement, and 4) Placebo. The exercise groups followed an eight-week protocol, three sessions per week, consisting of 30 minutes of aerobic activity at 60–70% of heart rate reserve and 30 minutes of resistance training. The supplementation groups received 1,500 mg/day of dried nettle extract (three doses of 500 mg).&lt;br&gt;Results: Between-group analysis showed that the combined group (Exercise + Nettle) led to a significant increase in TAC levels (P &lt; 0.001) and significant reductions in IL-1β (P = 0.011) and CRP (P = 0.008) compared to the Exercise + Placebo group. Additionally, compared to the Nettle Supplement group, the combined group achieved a greater reduction in CRP (P = 0.001).&lt;br&gt;Conclusion: The findings suggest that both concurrent exercise and nettle supplementation alone can improve inflammatory status and antioxidant capacity in women with metabolic syndrome. However, combining these interventions produces a synergistic effect and may serve as a more effective strategy in lifestyle modification programs for managing this syndrome.</Abstract>
			<OtherAbstract Language="FA">Background and Objective: Metabolic syndrome is associated with systemic inflammation and oxidative stress, which increase the risk of cardiovascular diseases. This study aimed to investigate the effects of eight weeks of concurrent exercise training and nettle supplementation the inflammatory-anti-inflammatory balance in women with metabolic syndrome.&lt;br&gt;Methods: In this semi-experimental study, 60 women with metabolic syndrome (aged 35–45 years) were randomly assigned to four groups of 15 participants each: 1) Exercise + Placebo, 2) Nettle Supplement, 3) Exercise + Nettle Supplement, and 4) Placebo. The exercise groups followed an eight-week protocol, three sessions per week, consisting of 30 minutes of aerobic activity at 60–70% of heart rate reserve and 30 minutes of resistance training. The supplementation groups received 1,500 mg/day of dried nettle extract (three doses of 500 mg).&lt;br&gt;Results: Between-group analysis showed that the combined group (Exercise + Nettle) led to a significant increase in TAC levels (P &lt; 0.001) and significant reductions in IL-1β (P = 0.011) and CRP (P = 0.008) compared to the Exercise + Placebo group. Additionally, compared to the Nettle Supplement group, the combined group achieved a greater reduction in CRP (P = 0.001).&lt;br&gt;Conclusion: The findings suggest that both concurrent exercise and nettle supplementation alone can improve inflammatory status and antioxidant capacity in women with metabolic syndrome. However, combining these interventions produces a synergistic effect and may serve as a more effective strategy in lifestyle modification programs for managing this syndrome.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Metabolic Syndrome</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Exercise training</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nettle</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Inflammation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">oxidative stress</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_245528_c05d6519dc5d522c1043bd59126b91d6.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Ahvaz Jundishapur University of Medical Sciences</PublisherName>
				<JournalTitle>Jundishapur Journal of Medical Sciences</JournalTitle>
				<Issn></Issn>
				<Volume>25</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Risk Factors and Prevalence of Endophthalmitis after Intravitreal Injection of Anti-VEGF Drugs: A Systematic Review and Meta-Analysis</ArticleTitle>
<VernacularTitle>Risk Factors and Prevalence of Endophthalmitis after Intravitreal Injection of Anti-VEGF Drugs: A Systematic Review and Meta-Analysis</VernacularTitle>
			<FirstPage>77</FirstPage>
			<LastPage>89</LastPage>
			<ELocationID EIdType="pii">250396</ELocationID>
			
<ELocationID EIdType="doi">10.22118/jsmj.2026.568368.4123</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Adabi</LastName>
<Affiliation>Research Center for Food Hygiene and Safety, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Rozhin</FirstName>
					<LastName>Kasiri</LastName>
<Affiliation>Infectious Ophthalmologic Research Center, Ahvaz Jondishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Shahbazi</LastName>
<Affiliation>Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Zahra</FirstName>
					<LastName>Shokati Eshkiki</LastName>
<Affiliation>Alimentary Tract Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>12</Month>
					<Day>24</Day>
				</PubDate>
			</History>
		<Abstract>To determine the worldwide incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) medications, we carried out a systematic review and meta-analysis. To locate relevant research published up to June 2024, searches were conducted via PubMed, Scopus, Web of Science, and Google Scholar. Among the search phrases used were &quot;endophthalmitis,&quot; &quot;intravitreal injection,&quot; &quot;anti-VEGF,&quot; &quot;bevacizumab,&quot; &quot;Avastin,&quot; &quot;aflibercept,&quot; and &quot;ranibizumab.&quot; The incidence of endophthalmitis in individuals who received intravitreal injection of anti-VEGF alone was only recorded in these trials. 136 of the 1563 identified references could be included in the meta-analysis after duplicates and irrelevant papers were eliminated. After evaluating 23,809,816 intravitreal anti-VEGF injections, the estimated incidence of endophthalmitis was 0.0382 (95% CI: 0.034 to 0.042). The study&#039;s findings indicate that endophthalmitis is uncommon after intravitreal injections of anti-VEGF drugs; yet, paying close attention to infection prevention and management guidelines is still crucial due to the potentially serious repercussions of this condition.</Abstract>
			<OtherAbstract Language="FA">To determine the worldwide incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) medications, we carried out a systematic review and meta-analysis. To locate relevant research published up to June 2024, searches were conducted via PubMed, Scopus, Web of Science, and Google Scholar. Among the search phrases used were &quot;endophthalmitis,&quot; &quot;intravitreal injection,&quot; &quot;anti-VEGF,&quot; &quot;bevacizumab,&quot; &quot;Avastin,&quot; &quot;aflibercept,&quot; and &quot;ranibizumab.&quot; The incidence of endophthalmitis in individuals who received intravitreal injection of anti-VEGF alone was only recorded in these trials. 136 of the 1563 identified references could be included in the meta-analysis after duplicates and irrelevant papers were eliminated. After evaluating 23,809,816 intravitreal anti-VEGF injections, the estimated incidence of endophthalmitis was 0.0382 (95% CI: 0.034 to 0.042). The study&#039;s findings indicate that endophthalmitis is uncommon after intravitreal injections of anti-VEGF drugs; yet, paying close attention to infection prevention and management guidelines is still crucial due to the potentially serious repercussions of this condition.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Endophthalmitis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Intravitreal Injection</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anti-VEGF</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsmj.ajums.ac.ir/article_250396_fb182a5f056d50bbbfaabcdc3acb0748.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
